Yuegui Guo

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

YAP/TAZ enhances P-body formation to promote tumorigenesis.

YAP/TAZ enhances P-body formation to promote tumorigenesis.

Journal: eLife

Published: July 24, 2024

Computer-aided molecular design and optimization of potent inhibitors disrupting APC‒Asef interaction.

Computer-aided molecular design and optimization of potent inhibitors disrupting APC‒Asef interaction.

Journal: Acta pharmaceutica Sinica. B

Published: October 16, 2023

Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker.

Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker.

Journal: Journal of cancer research and clinical oncology

Published: June 06, 2023

ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.

ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 24, 2023

Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.

Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.

Journal: Journal of cancer research and clinical oncology

Published: May 11, 2022

Rational design of a sensitivity-enhanced tracer for discovering efficient APC-Asef inhibitors.

Rational design of a sensitivity-enhanced tracer for discovering efficient APC-Asef inhibitors.

Journal: Nature communications

Published: November 25, 2021

CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis.

CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis.

Journal: Nature communications

Published: June 30, 2021

Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.

Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.

Journal: EBioMedicine

Published: October 04, 2020

LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.

LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.

Journal: Oncogene

Published: November 25, 2019

Clinical outcomes and risk factors of secondary extraintestinal manifestation in ulcerative colitis: results of a multicenter and long-term follow-up retrospective study.

Clinical outcomes and risk factors of secondary extraintestinal manifestation in ulcerative colitis: results of a multicenter and long-term follow-up retrospective study.

Journal: PeerJ

Published: February 01, 2019

Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer.

Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer.

Journal: The Journal of international medical research

Published: January 09, 2019

Small heat shock protein CRYAB inhibits intestinal mucosal inflammatory responses and protects barrier integrity through suppressing IKKβ activity.

Small heat shock protein CRYAB inhibits intestinal mucosal inflammatory responses and protects barrier integrity through suppressing IKKβ activity.

Journal: Mucosal immunology

Published: January 02, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026